ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,642Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 117

$520K Total Retail Price of All Prescriptions

Rank: 31 out of 117

362 Patients Receiving at Least One Drug in Part D
99%Patients 65 Years and Older
6% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 362 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

13% of this provider’s 362 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 9,610 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
LEVOTHYROXINE SODIUM 442 442 1 2
FUROSEMIDE 386 384 2 3
DONEPEZIL HCL 374 374 3 10
WARFARIN SODIUM 361 361 4 9
OMEPRAZOLE 316 314 5 6
AMLODIPINE BESYLATE 304 304 6 5
SIMVASTATIN 282 282 7 1
NAMENDA 274 274 8 14
LISINOPRIL 234 230 9 4
ALENDRONATE SODIUM 216 216 10 21
METOPROLOL TARTRATE 213 213 11 8
HYDROCODONE-ACETAMINOPHEN 176 173 S3 12 7
HYDROCHLOROTHIAZIDE 158 158 13 13
METOPROLOL SUCCINATE 157 157 14 12
MELOXICAM 157 156 14 61
POTASSIUM CHLORIDE 150 150 16 17
CITALOPRAM HBR 143 143 17 19
GABAPENTIN 119 119 18 16
TRAMADOL HCL 108 108 19 18
ESCITALOPRAM OXALATE 103 103 20 42
CLOPIDOGREL 102 102 21 30
POLYETHYLENE GLYCOL 3350 99 99 22 32
ATORVASTATIN CALCIUM 96 96 23 15
QUETIAPINE FUMARATE 91 91 24 36
PANTOPRAZOLE SODIUM 89 89 25 26
CARBIDOPA-LEVODOPA 86 86 26 45
OXYBUTYNIN CHLORIDE ER 86 86 26 77
MIRTAZAPINE 85 85 28 25
LOSARTAN POTASSIUM 83 83 29 23
CARVEDILOL 80 80 30 24
SERTRALINE HCL 79 73 31 22
PAROXETINE HCL 79 79 31 63
KLOR-CON M20 75 75 33 34
ENALAPRIL MALEATE 74 74 34 33
PLAVIX 69 69 35 47
METFORMIN HCL 68 68 36 11
ATENOLOL 67 67 37 20
TAMSULOSIN HCL 66 66 38 28
RISPERIDONE 66 66 38 39
JANUVIA 66 66 38 64
ZOLPIDEM TARTRATE 62 62 41 27
KLOR-CON M10 57 57 42 89
CIPROFLOXACIN HCL 55 55 43 65
CLOTRIMAZOLE-BETAMETHASONE 54 54 44 191
HYDRALAZINE HCL 53 53 45 54
ADVAIR DISKUS 53 53 45 51
GLIMEPIRIDE 53 53 45 69
DIOVAN 50 50 48 31
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 1, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.